Curatis and Neupharma announce exclusive licensing agreement for corticorelin in Japan

Ad hoc announcement pursuant to Art. 53 LR

Liestal, Switzerland / Tokyo, Japan, 11 March 2026: Curatis Holding AG and Neupharma announce an exclusive licensing agreement for corticorelin in Japan.